A metabolic switch from GLS2 to GLS1 was observed in a series of tissues representing progressive pathologic states mimicking HCC oncogenic transformation; moreover high expression of GLS1 and low expression of GLS2 in HCC was found to correlate with survival in HCC patients20. This evidence concerns the gene GLS2 and hepatocellular carcinoma.